The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...
Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...
A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...
Lab monkeys thought to have COVID-19, hepatitis C virus and herpes escaped after the transport vehicle carrying them ...
Risankizumab outperformed vedolizumab in various outcomes, including clinical response at 12 and 52 weeks, among patients ...
Use of GLP-1 receptor agonists did not appear to affect esophageal function among patients with type 2 diabetes, according to study results presented at ACG Annual Scientific Meeting.Research has ...
Xiidra, usually prescribed for dry eye disease, led to significant improvements in contact lens discomfort and dryness within ...
Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...
Adult patients with cancer who had adenomas at baseline and immune checkpoint inhibitor-mediated diarrhea and colitis faced a ...
Use of teduglutide appeared safe for patients with short bowel syndrome, with no increased incidence of gastrointestinal ...
In this video, Leo I. Gordon, MD, FACP, discusses the growing view that follicular lymphoma could be viewed as “curable.” ...
Environmental exposure to trichloroethylene may increase the risk for developing Parkinson’s disease, particularly in heavily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback